Nothing Special   »   [go: up one dir, main page]

FR2276832A1 - NEW PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION - Google Patents

NEW PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION

Info

Publication number
FR2276832A1
FR2276832A1 FR7520946A FR7520946A FR2276832A1 FR 2276832 A1 FR2276832 A1 FR 2276832A1 FR 7520946 A FR7520946 A FR 7520946A FR 7520946 A FR7520946 A FR 7520946A FR 2276832 A1 FR2276832 A1 FR 2276832A1
Authority
FR
France
Prior art keywords
preparation
pharmaceutical compositions
new pharmaceutical
new
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7520946A
Other languages
French (fr)
Other versions
FR2276832B1 (en
Inventor
Joachim Franz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2276832A1 publication Critical patent/FR2276832A1/en
Application granted granted Critical
Publication of FR2276832B1 publication Critical patent/FR2276832B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
FR7520946A 1974-07-05 1975-07-03 NEW PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION Granted FR2276832A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH931274 1974-07-05

Publications (2)

Publication Number Publication Date
FR2276832A1 true FR2276832A1 (en) 1976-01-30
FR2276832B1 FR2276832B1 (en) 1978-10-06

Family

ID=4350618

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7520946A Granted FR2276832A1 (en) 1974-07-05 1975-07-03 NEW PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION

Country Status (14)

Country Link
JP (1) JPS5132724A (en)
AU (1) AU8280175A (en)
BE (1) BE831042A (en)
DE (1) DE2528516A1 (en)
ES (1) ES439113A1 (en)
FR (1) FR2276832A1 (en)
GB (1) GB1518683A (en)
HU (1) HU170215B (en)
IL (1) IL47634A (en)
NL (1) NL7507798A (en)
NZ (1) NZ178011A (en)
SE (1) SE7507414L (en)
YU (1) YU170475A (en)
ZA (1) ZA754304B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041030A1 (en) * 1980-05-28 1981-12-02 Pierre Fabre S.A. Compositions for topical use containing Ergot or Vinca Rosea alkaloids for treatment of hyperseborrhoea, and their preparation
FR2548025A1 (en) * 1983-07-01 1985-01-04 Nitto Electric Ind Co EXCIPIENT COMPRISING AN ALCOHOLIC ADJUVANT AND A SOLVENT FOR THE PERCUTANEOUS ADMINISTRATION OF A PHYSIOLOGICALLY ACTIVE AGENT
EP0279986A1 (en) * 1987-02-26 1988-08-31 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
EP0295411A1 (en) * 1987-05-15 1988-12-21 Sansho Co., Ltd. Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or a salt thereof
EP0521799A1 (en) * 1991-07-05 1993-01-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ophthalmic compositions

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54163810A (en) * 1978-06-14 1979-12-26 Mundipharma Ag Gel composition for local coating
JPS56159310A (en) * 1980-05-14 1981-12-08 Showa Denko Kk Preparation of monofilament having high strength and knot strength
JPS59216825A (en) * 1983-05-23 1984-12-06 Takeda Chem Ind Ltd External drug for transcutaneous absorption
US4752612A (en) * 1983-07-01 1988-06-21 Nitto Electrical Industrial Co., Ltd. Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
US5128376A (en) * 1983-07-01 1992-07-07 Nitto Denko Corporation Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator
JPS6013720A (en) * 1983-07-01 1985-01-24 Nitto Electric Ind Co Ltd Percutaneous administration of physiological activator using adjuvant, solvent and diol modulator
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
JPH0735331B2 (en) * 1986-01-16 1995-04-19 久光製薬株式会社 External gel formulation
JPH0735332B2 (en) * 1986-02-25 1995-04-19 久光製薬株式会社 Cream formulation for external use
JPH0759519B2 (en) * 1987-02-23 1995-06-28 株式会社資生堂 Transdermal absorption enhancer and external preparation for skin containing the same
DE3710216A1 (en) * 1987-03-27 1988-10-06 Rentschler Arzneimittel USE OF DIHYDROERGOTAMINE AND ITS SALTS FOR LOCAL TREATMENT OF TROPHIC DISORDERS
US5223261A (en) * 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
CH679119A5 (en) * 1988-05-13 1991-12-31 Sandoz Ag
GB2230444B (en) * 1989-04-19 1993-12-08 Ritchie Swanson John Therapeutic compositions.
US5219877A (en) * 1989-09-25 1993-06-15 Bristol-Myers Squibb Company Lauryl alcohol as skin penetration enhancer for topical imidazole agents
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
WO1991016929A1 (en) * 1990-05-10 1991-11-14 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
US5681852A (en) * 1993-11-12 1997-10-28 The Procter & Gamble Company Desquamation compositions
ES2171522T3 (en) * 1993-11-12 2002-09-16 Procter & Gamble SCALING COMPOSITIONS CONTAINING SALICILIC ACID AND BIPOLAR COMPOUNDS.
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
US6005135A (en) * 1996-03-21 1999-12-21 Exxon Chemical Patents Inc. Water-borne polymeric vehicle for coating compositions containing an amine or ammonium salt of phenolic ester alcohols
US6096326A (en) * 1997-08-15 2000-08-01 Scandinavian-American Import/Export Corporation Skin care compositions and use
AU775904B2 (en) † 1999-02-08 2004-08-19 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
DE602007009377D1 (en) 2006-05-30 2010-11-04 Intarcia Therapeutics Inc SECONDARY FLOW MODULATOR WITH AN INTERNAL CHANNEL FOR AN OSMOTIC OUTPUT SYSTEM
MX2009001114A (en) 2006-08-09 2009-02-10 Intarcia Therapeutics Inc Osmotic delivery systems and piston assemblies.
CN105688191A (en) 2007-04-23 2016-06-22 精达制药公司 Suspension formulations of insulinotropic peptides and uses thereof
KR101514342B1 (en) * 2007-11-22 2015-04-22 가부시키가이샤 메드렉스 External preparation composition comprising fatty acid-based inoic liquid as active ingredient
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
DK2462246T3 (en) 2009-09-28 2017-11-06 Intarcia Therapeutics Inc QUICK ESTABLISHMENT AND / OR END OF SIGNIFICANT STEADY-STATE PHARMACEUTICAL DELIVERY
JP2012020991A (en) 2010-06-16 2012-02-02 Takasago Internatl Corp Transdermal absorption promoter, and external skin formulation thereof
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
JP5820206B2 (en) 2011-09-13 2015-11-24 日東電工株式会社 Transdermal absorption enhancing composition and patch preparation
JP5820207B2 (en) 2011-09-13 2015-11-24 日東電工株式会社 Transdermal absorption enhancing composition and patch preparation
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US20170239173A1 (en) 2014-10-30 2017-08-24 Asahi Kasei Kabushiki Kaisha Transdermal absorption enhancer and transdermal absorption enhancement aid
CA2987766A1 (en) 2015-06-03 2016-12-08 Intarcia Therapeutics, Inc. Implant placement and removal systems
SG10201913699QA (en) 2016-05-16 2020-03-30 Intarcia Therapeutics Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
JP7286542B2 (en) 2017-01-03 2023-06-05 インターシア セラピューティクス，インコーポレイティド A method comprising continuous administration of a GLP-1 receptor agonist and co-administration of drugs

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041030A1 (en) * 1980-05-28 1981-12-02 Pierre Fabre S.A. Compositions for topical use containing Ergot or Vinca Rosea alkaloids for treatment of hyperseborrhoea, and their preparation
FR2483235A1 (en) * 1980-05-28 1981-12-04 Fabre Sa Pierre TOPICAL COMPOSITIONS CONTAINING RYE AND VINCA ROSEA ERGOT ALKALOIDS FOR THE TREATMENT OF HYPERSEBORRHOES
FR2548025A1 (en) * 1983-07-01 1985-01-04 Nitto Electric Ind Co EXCIPIENT COMPRISING AN ALCOHOLIC ADJUVANT AND A SOLVENT FOR THE PERCUTANEOUS ADMINISTRATION OF A PHYSIOLOGICALLY ACTIVE AGENT
EP0279986A1 (en) * 1987-02-26 1988-08-31 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
EP0295411A1 (en) * 1987-05-15 1988-12-21 Sansho Co., Ltd. Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or a salt thereof
EP0521799A1 (en) * 1991-07-05 1993-01-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ophthalmic compositions

Also Published As

Publication number Publication date
ES439113A1 (en) 1977-10-16
GB1518683A (en) 1978-07-19
DE2528516A1 (en) 1976-01-22
YU170475A (en) 1984-02-29
AU8280175A (en) 1977-01-13
NL7507798A (en) 1976-01-07
JPS5132724A (en) 1976-03-19
NZ178011A (en) 1978-07-28
IL47634A (en) 1978-07-31
IL47634A0 (en) 1975-10-15
HU170215B (en) 1977-04-28
ZA754304B (en) 1977-02-23
FR2276832B1 (en) 1978-10-06
SE7507414L (en) 1976-01-07
BE831042A (en) 1976-01-05

Similar Documents

Publication Publication Date Title
FR2276832A1 (en) NEW PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION
BE810197A (en) NEW ELECTRODES AND THEIR PREPARATION
FR2327764A1 (en) NEW PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION
FR2283679A1 (en) 4-ARYLPIPERIDINES 1,3,4-TRISUBSTITUES AND THEIR PREPARATION
FR2285891A1 (en) NEW BENZODIAZEPINES AND THEIR PREPARATION
BE832860A (en) BENZO-ISOQUINOLEINE-DIONES AND THEIR PREPARATION
BE833586A (en) AMINOBENZAZOCINES AND THEIR PREPARATION
BE832921A (en) NEW RIFAMYCINS AND THEIR PREPARATION
BE829082A (en) NEW DIAMINES, THEIR PREPARATION AND THEIR APPLICATION
BE825982A (en) TRIAZOLOQUINAZOLINES AND THEIR PREPARATION
FR2283689A1 (en) NEW CEPHAMYCINS, THEIR PREPARATION AND THEIR APPLICATION
FR2290193A1 (en) N2-NAPHTALENESULFONYL-L-ARGININE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2276833A1 (en) NEW GALENIC COMPOSITIONS AND THEIR PREPARATION
BE830442A (en) NEW BENZYLAMINES THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING
BE831743A (en) NEW ANTIBIOTIC SUBSTANCES AND THEIR PREPARATION
FR2313059A1 (en) NEW STABLE PHARMACEUTICAL SOLUTIONS AND THEIR PREPARATION
FR2274291A1 (en) NEW PHARMACEUTICAL COMPOSITIONS AND PROCESS FOR THEIR PREPARATION
BE826925A (en) NEW PYRROLODIAZEPINES AND THEIR PREPARATION
BE820256A (en) NEW PHENOXYALKYLAMINES AND THEIR PREPARATION
BE840608A (en) NEW PHARMACEUTICAL COMPOSITIONS
FR2287220A1 (en) NEW ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION PROCESS
FR2285871A1 (en) PHARMACEUTICAL COMPOSITIONS
BE826986A (en) NEW BENZODIAZEPINES AND THEIR PREPARATION
BE829153A (en) 5-PHENYL-THIAZOLIDINE-4-ONES AND THEIR PREPARATION
BE832464A (en) 3,4-DIHYDRO-2H-ISOQUINOLEINE-1-THIONES AND THEIR PREPARATION

Legal Events

Date Code Title Description
ST Notification of lapse